Motley Fool Asset Management LLC Purchases 2,423 Shares of CVS Health Co. (NYSE:CVS)

Motley Fool Asset Management LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 7.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 35,436 shares of the pharmacy operator’s stock after buying an additional 2,423 shares during the period. Motley Fool Asset Management LLC’s holdings in CVS Health were worth $2,798,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. SOA Wealth Advisors LLC. increased its stake in CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 133 shares in the last quarter. Apella Capital LLC increased its stake in CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after purchasing an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC increased its stake in CVS Health by 4.1% in the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after purchasing an additional 141 shares in the last quarter. WealthShield Partners LLC grew its holdings in shares of CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after buying an additional 141 shares during the last quarter. Finally, Sugarloaf Wealth Management LLC grew its holdings in shares of CVS Health by 9.5% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock valued at $129,000 after buying an additional 142 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on CVS shares. Wells Fargo & Company reduced their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Royal Bank of Canada lowered their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Piper Sandler raised their price objective on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, March 15th. Barclays began coverage on shares of CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 target price on the stock. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $87.00 target price on shares of CVS Health in a report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Trading Down 0.2 %

CVS Health stock traded down $0.15 during trading hours on Friday, reaching $67.18. The stock had a trading volume of 6,393,752 shares, compared to its average volume of 10,655,146. The company has a fifty day simple moving average of $74.61 and a 200-day simple moving average of $73.67. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a market cap of $84.68 billion, a PE ratio of 10.40, a PEG ratio of 0.90 and a beta of 0.52.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the company posted $1.99 EPS. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. Analysts forecast that CVS Health Co. will post 8.31 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. CVS Health’s dividend payout ratio is 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.